The global Biologics Monoclonal Antibodies Drug market was valued at 241090 million in 2024 and is projected to reach US$ 555970 million by 2031, at a CAGR of 13.0% during the forecast period.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
The monoclonal antibody medicine market is driven by the growing demand for targeted and personalized therapies and the significant advancements in biotechnology and antibody engineering. Monoclonal antibodies (mAbs) offer precise targeting of specific antigens, making them highly effective in treating various diseases, including cancer, autoimmune disorders, and infectious diseases. Their ability to modulate the immune response and their potential for fewer side effects compared to traditional treatments have fueled their popularity among healthcare providers and patients. Moreover, the development of novel mAbs and the expansion of approved indications for existing therapies further contribute to market growth. However, the market also faces challenges, including the high cost of mAb therapies, which can limit patient access and reimbursement. Additionally, the complex manufacturing process and regulatory requirements for mAb medicines can be obstacles for new market entrants. To succeed in this competitive market, manufacturers must focus on improving affordability, exploring biosimilar opportunities, and investing in research and development to develop innovative and differentiated monoclonal antibody medicines that address unmet medical needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics Monoclonal Antibodies Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Biologics Monoclonal Antibodies Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Monoclonal Antibodies Drug. This report contains market size and forecasts of Biologics Monoclonal Antibodies Drug in global, including the following market information:
Global Biologics Monoclonal Antibodies Drug market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Biologics Monoclonal Antibodies Drug companies in 2024 (%)
Total Market by Segment:
Global Biologics Monoclonal Antibodies Drug market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Biologics Monoclonal Antibodies Drug market segment percentages, by Type, 2024 (%)
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Global Biologics Monoclonal Antibodies Drug market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Biologics Monoclonal Antibodies Drug market segment percentages, by Application, 2024 (%)
Cancer
Autoimmune Disease
Other
Global Biologics Monoclonal Antibodies Drug market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Biologics Monoclonal Antibodies Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologics Monoclonal Antibodies Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Biologics Monoclonal Antibodies Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Sobi
Innovent Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologics Monoclonal Antibodies Drug, market overview.
Chapter 2: Global Biologics Monoclonal Antibodies Drug market size in revenue.
Chapter 3: Detailed analysis of Biologics Monoclonal Antibodies Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologics Monoclonal Antibodies Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Biologics Monoclonal Antibodies Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Biologics Monoclonal Antibodies Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics Monoclonal Antibodies Drug Overall Market Size
2.1 Global Biologics Monoclonal Antibodies Drug Market Size: 2024 VS 2031
2.2 Global Biologics Monoclonal Antibodies Drug Market Size, Prospects & Forecasts: 2020-2031
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologics Monoclonal Antibodies Drug Players in Global Market
3.2 Top Global Biologics Monoclonal Antibodies Drug Companies Ranked by Revenue
3.3 Global Biologics Monoclonal Antibodies Drug Revenue by Companies
3.4 Top 3 and Top 5 Biologics Monoclonal Antibodies Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Biologics Monoclonal Antibodies Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Biologics Monoclonal Antibodies Drug Players in Global Market
3.6.1 List of Global Tier 1 Biologics Monoclonal Antibodies Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologics Monoclonal Antibodies Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Market Size Markets, 2024 & 2031
4.1.2 Infliximab
4.1.3 Rituximab
4.1.4 Trastuzumab
4.1.5 Adalimumab
4.1.6 Other
4.2 Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue, 2026-2031
4.2.3 Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Market Size, 2024 & 2031
5.1.2 Cancer
5.1.3 Autoimmune Disease
5.1.4 Other
5.2 Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue, 2026-2031
5.2.3 Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
6 Sights by Region
6.1 By Region - Global Biologics Monoclonal Antibodies Drug Market Size, 2024 & 2031
6.2 By Region - Global Biologics Monoclonal Antibodies Drug Revenue & Forecasts
6.2.1 By Region - Global Biologics Monoclonal Antibodies Drug Revenue, 2020-2025
6.2.2 By Region - Global Biologics Monoclonal Antibodies Drug Revenue, 2026-2031
6.2.3 By Region - Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
6.3 North America
6.3.1 By Country - North America Biologics Monoclonal Antibodies Drug Revenue, 2020-2031
6.3.2 United States Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.3.3 Canada Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.3.4 Mexico Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4 Europe
6.4.1 By Country - Europe Biologics Monoclonal Antibodies Drug Revenue, 2020-2031
6.4.2 Germany Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4.3 France Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4.4 U.K. Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4.5 Italy Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4.6 Russia Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4.7 Nordic Countries Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.4.8 Benelux Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.5 Asia
6.5.1 By Region - Asia Biologics Monoclonal Antibodies Drug Revenue, 2020-2031
6.5.2 China Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.5.3 Japan Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.5.4 South Korea Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.5.5 Southeast Asia Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.5.6 India Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.6 South America
6.6.1 By Country - South America Biologics Monoclonal Antibodies Drug Revenue, 2020-2031
6.6.2 Brazil Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.6.3 Argentina Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biologics Monoclonal Antibodies Drug Revenue, 2020-2031
6.7.2 Turkey Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.7.3 Israel Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.7.4 Saudi Arabia Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
6.7.5 UAE Biologics Monoclonal Antibodies Drug Market Size, 2020-2031
7 Companies Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics Monoclonal Antibodies Drug Major Product Offerings
7.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics Monoclonal Antibodies Drug Major Product Offerings
7.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics Monoclonal Antibodies Drug Major Product Offerings
7.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Biologics Monoclonal Antibodies Drug Major Product Offerings
7.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.4.5 Sanofi Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Major Product Offerings
7.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics Monoclonal Antibodies Drug Major Product Offerings
7.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.6.5 Pfizer Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Major Product Offerings
7.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Biologics Monoclonal Antibodies Drug Major Product Offerings
7.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.8.5 Novartis Key News & Latest Developments
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Biologics Monoclonal Antibodies Drug Major Product Offerings
7.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.9.5 Merck Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Corporate Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Biologics Monoclonal Antibodies Drug Major Product Offerings
7.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.10.5 Biogen Key News & Latest Developments
7.11 Sobi
7.11.1 Sobi Corporate Summary
7.11.2 Sobi Business Overview
7.11.3 Sobi Biologics Monoclonal Antibodies Drug Major Product Offerings
7.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.11.5 Sobi Key News & Latest Developments
7.12 Innovent Biologics
7.12.1 Innovent Biologics Corporate Summary
7.12.2 Innovent Biologics Business Overview
7.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Major Product Offerings
7.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue in Global Market (2020-2025)
7.12.5 Innovent Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biologics Monoclonal Antibodies Drug Market Opportunities & Trends in Global Market
Table 2. Biologics Monoclonal Antibodies Drug Market Drivers in Global Market
Table 3. Biologics Monoclonal Antibodies Drug Market Restraints in Global Market
Table 4. Key Players of Biologics Monoclonal Antibodies Drug in Global Market
Table 5. Top Biologics Monoclonal Antibodies Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Biologics Monoclonal Antibodies Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Biologics Monoclonal Antibodies Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Biologics Monoclonal Antibodies Drug Product Type
Table 9. List of Global Tier 1 Biologics Monoclonal Antibodies Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics Monoclonal Antibodies Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type – Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2024 & 2031
Table 12. Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue (US$, Mn), 2026-2031
Table 14. Segmentation by Application– Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2024 & 2031
Table 15. Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 17. By Region– Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2024 & 2031
Table 18. By Region - Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 20. By Country - North America Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 22. By Country - Europe Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Asia Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 26. By Country - South America Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 28. By Country - Middle East & Africa Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2026-2031
Table 30. Roche Corporate Summary
Table 31. Roche Biologics Monoclonal Antibodies Drug Product Offerings
Table 32. Roche Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 33. Roche Key News & Latest Developments
Table 34. Amgen Corporate Summary
Table 35. Amgen Biologics Monoclonal Antibodies Drug Product Offerings
Table 36. Amgen Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 37. Amgen Key News & Latest Developments
Table 38. AbbVie Corporate Summary
Table 39. AbbVie Biologics Monoclonal Antibodies Drug Product Offerings
Table 40. AbbVie Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 41. AbbVie Key News & Latest Developments
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Biologics Monoclonal Antibodies Drug Product Offerings
Table 44. Sanofi Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 45. Sanofi Key News & Latest Developments
Table 46. Johnson & Johnson Corporate Summary
Table 47. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product Offerings
Table 48. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Corporate Summary
Table 51. Pfizer Biologics Monoclonal Antibodies Drug Product Offerings
Table 52. Pfizer Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 53. Pfizer Key News & Latest Developments
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Biologics Monoclonal Antibodies Drug Product Offerings
Table 56. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Novartis Corporate Summary
Table 59. Novartis Biologics Monoclonal Antibodies Drug Product Offerings
Table 60. Novartis Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 61. Novartis Key News & Latest Developments
Table 62. Merck Corporate Summary
Table 63. Merck Biologics Monoclonal Antibodies Drug Product Offerings
Table 64. Merck Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 65. Merck Key News & Latest Developments
Table 66. Biogen Corporate Summary
Table 67. Biogen Biologics Monoclonal Antibodies Drug Product Offerings
Table 68. Biogen Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 69. Biogen Key News & Latest Developments
Table 70. Sobi Corporate Summary
Table 71. Sobi Biologics Monoclonal Antibodies Drug Product Offerings
Table 72. Sobi Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 73. Sobi Key News & Latest Developments
Table 74. Innovent Biologics Corporate Summary
Table 75. Innovent Biologics Biologics Monoclonal Antibodies Drug Product Offerings
Table 76. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue (US$, Mn) & (2020-2025)
Table 77. Innovent Biologics Key News & Latest Developments
List of Figures
Figure 1. Biologics Monoclonal Antibodies Drug Product Picture
Figure 2. Biologics Monoclonal Antibodies Drug Segment by Type in 2024
Figure 3. Biologics Monoclonal Antibodies Drug Segment by Application in 2024
Figure 4. Global Biologics Monoclonal Antibodies Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Biologics Monoclonal Antibodies Drug Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Biologics Monoclonal Antibodies Drug Revenue: 2020-2031 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Biologics Monoclonal Antibodies Drug Revenue in 2024
Figure 9. Segmentation by Type – Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2024 & 2031
Figure 10. Segmentation by Type - Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 11. Segmentation by Application – Global Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2024 & 2031
Figure 12. Segmentation by Application - Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 13. By Region - Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 14. By Country - North America Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 15. United States Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 16. Canada Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 17. Mexico Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 18. By Country - Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 19. Germany Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 20. France Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 21. U.K. Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 22. Italy Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 23. Russia Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 24. Nordic Countries Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 25. Benelux Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 26. By Region - Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 27. China Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 28. Japan Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 29. South Korea Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 30. Southeast Asia Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 31. India Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 32. By Country - South America Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 33. Brazil Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 34. Argentina Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 35. By Country - Middle East & Africa Biologics Monoclonal Antibodies Drug Revenue Market Share, 2020-2031
Figure 36. Turkey Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 37. Israel Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 38. Saudi Arabia Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 39. UAE Biologics Monoclonal Antibodies Drug Revenue, (US$, Mn), 2020-2031
Figure 40. Roche Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Amgen Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. AbbVie Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Sanofi Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Pfizer Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Novartis Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Merck Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Biogen Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Sobi Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
